Dysfunction of CD27+IgD+B cells correlates with aggravated systemic lupus erythematosus

Objective The apoptotic signaling pathway is obviously disordered in systemic lupus erythematosus (SLE). Natural IgM (nIgM) is important in clearing apoptotic cells and preventing them from triggering deleterious autoimmunity. B-1 and innate-like B (ILBs) cells are the main nIgM producers. Human CD27(+)IgD(+) B cells (un-switched memory B cells) are considered ILBs. However, their functional properties in SLE remain undefined. Methods Peripheral blood sample of 50 SLE patients and 50 healthy controls were collected, and twelve SLE patients were assessed in a follow-up study. The amount of CD27(+)IgD(+) B cell in each population was analyzed by flow cytometry. The IgM and IL-10 levels of CD27(+)IgD(+) B cell were assessed by ELISPOT and qRT-PCR, respectively. SPSS 17.0 (SPSS, USA) was employed for data analysis. P < 0.05 indicated statistical significance. Result The amounts of CD27(+)IgD(+)B cell were significantly decreased in SLE patients than healthy control (P < 0.01). CD27(+)IgD(+)B cell amounts were positively correlated with WBC (r = 0.337, P =0 .017), platelet count (r = 0.396, P =0 .004), and serum C3 levels (r = 0.415, P =0 .003) and negatively correlated with serum creatinine levels (r= -0.285, P =0 .045), SLEDAI(r= -0.724, P =0 .000), and anti-d5DNA(r= -0.477, P = 0.000). The IgM and IL-10 levels of CD27(+)IgD(+)B in active SLE were decreased than healthy control (P < 0.001). Moreover, CD27(+)IgD(+)B cells are increased in SLE cases after treatment than before treatment (P <0 .001). Conclusion The amounts of CD27(+)IgD(+)B cell were significantly decreased in SLE patients compared with the healthy population, and CD27(+)IgD(+)B cell was verified to be correlated with clinical and immunological features in SLE patients.CD27(+)IgD(+)B cells had impaired function associated with IgM and IL-10 production in active SLE. Moreover, the amounts of CD27(+)IgD(+)B cells were recovered to the normal level in SLE cases with treatment-related disease remission.